Public recall detail

Tridural (tramadol HCl extended release tablets) - Removal of Tablet Markings in Certain Lots

medium
Recall Safety notice
Quick summary

Quick summary: Tridural (tramadol HCl extended release tablets) - Removal of Tablet Markings in Certain Lots .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Tridural (tramadol HCl extended release tablets) - Removal of Tablet Markings in Certain Lots .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand
ProductDIN #

Issue

As of April 2014, Paladin Labs Inc. stopped printing tablet markings (“LP 100”, “LP200” and “LP 300”) on the associated strengths of Tridural® (tramadol HCl extended release tablets). There was no change to the formulation and there is no quality issue with the product. For a period of time, there may be marked and unmarked tablets on the market. In order to avoid any potential confusion to the pharmacist or patient, the company will be reinstating markings on the tablets starting with the next manufactured lots.

Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...